Page last updated: 2024-12-10

ocotillol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ocotillol: cardioprotective agent; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3850493
MeSH IDM0515979

Synonyms (2)

Synonym
ocotillol
(20s,24s)-20,24-epoxydammarane-3beta,25-diol

Research Excerpts

Overview

Ocotillol is a derivate of pseudoginsenoside-F11, which is an ootillol-type ginsenosides found in American ginseng.

ExcerptReferenceRelevance
"Ocotillol is a derivate of pseudoginsenoside-F11, which is an ocotillol-type ginsenoside found in American ginseng."( Ginseng derivative ocotillol enhances neuronal activity through increased glutamate release: a possible mechanism underlying increased spontaneous locomotor activity of mice.
Fu, F; Heinbockel, T; Ma, S; Peng, W; Sun, L; Wang, ZJ; Zhu, C, 2011
)
1.42

Treatment

Pre-treatment with ocotillol ameliorated the decreased glutathione level and reduced the cumulated malondialdehyde in the heart tissue.

ExcerptReferenceRelevance
"Pre‑treatment with ocotillol ameliorated the decreased glutathione level and reduced the cumulated malondialdehyde in the heart tissue."( Protective effect of ocotillol against doxorubicin‑induced acute and chronic cardiac injury.
Fu, F; Fu, X; Kong, L; Li, G; Tang, M; Wang, H; Zhang, J; Zhou, X, 2014
)
1.04
"Pre-treatment with ocotillol could attenuate the changes of both SOD and MDA."( Cardioprotective effect of ocotillol, a derivate of pseudoginsenoside F11, on myocardial injury induced by isoproterenol in rats.
Fu, F; Han, B; Yu, C; Yu, X; Zhu, M, 2007
)
0.96

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacokinetic (PK) is a bridge linking the herbal medicines and their pharmacological responses."( Pharmacokinetic Characterizations of Ginsenoside Ocotillol, RT5 and F11, the Promising Agents for Alzheimer's Disease from American Ginseng, in Rats and Beagle Dogs.
An, Y; Geng, C; Hu, H; Li, R; Li, Y; Li, Z; Liu, Y; Wang, Z; Xu, F; Zhang, B; Zhao, C, 2019
)
0.77
" The values of Cmax and AUC(0-t) indicated ocotillol type ginsenosides had low systemic exposure and poor absorption into blood."( Pharmacokinetic Characterizations of Ginsenoside Ocotillol, RT5 and F11, the Promising Agents for Alzheimer's Disease from American Ginseng, in Rats and Beagle Dogs.
An, Y; Geng, C; Hu, H; Li, R; Li, Y; Li, Z; Liu, Y; Wang, Z; Xu, F; Zhang, B; Zhao, C, 2019
)
1.03

Bioavailability

ExcerptReferenceRelevance
" Fortunately, its bioavailability can be improved by means of pharmaceutical strategies, including nanoparticles, liposomes, emulsions, micelles, etc."( Biopharmaceutical characters and bioavailability improving strategies of ginsenosides.
Cai, Q; Chen, Q; He, H; Liu, D; Liu, Y; Miao, L; Pan, W; Tang, X; Xue, B; Yang, C; Yin, T; Zhang, Y; Zhou, L, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" However, it is severely restricted by its associated dose‑dependent cardiotoxicity, which may be attenuated by decreasing the cumulative dosage via combining with a non‑toxic 'sensitizer'."( Protective effect of ocotillol against doxorubicin‑induced acute and chronic cardiac injury.
Fu, F; Fu, X; Kong, L; Li, G; Tang, M; Wang, H; Zhang, J; Zhou, X, 2014
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (34)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (2.94)29.6817
2010's18 (52.94)24.3611
2020's15 (44.12)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.19

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.19 (24.57)
Research Supply Index3.56 (2.92)
Research Growth Index6.45 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.19)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (8.82%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (91.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]